A8G-21837-89176
3 vaccinations
14 coded responses
37 check-ins
14 free-text entries
0 call cases
- Sex
- —
- Age at first dose
- 46-50
- ZIP prefix
- 600 / IL
- Registered
- 2021-01-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-30
Dose 1 — Moderna
-
2021-01-01
Registered in v-safe
-
2021-01-01
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Axillary lymphadenopathy on same side as injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-06
-
2021-01-13
Survey response — day 14, dose 1MedDRA: Rash erythematous, Rash pruritic — Feeling: GoodFree text: Developed 2X4cm erythematous patch on shoulder, just below injection site. Mildly pruritic. Noticed it evening of Day 7, resolved by day 9. No systemic symptoms. Allergist thought it an inflammatory reaction (messaged photo to her)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-21
-
2021-01-27
Dose 2 — Moderna
-
2021-01-27
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-29
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Lymphadenopathy on same side as injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-30
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: LymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-31
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: ItchingFree text: LymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-01
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Lymphadenopathy, resolvingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-02
- 2021-02-03
- 2021-02-10
- 2021-02-17
-
2021-02-24
Survey response — day 28, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Ipsilateteral lymphadenopathy somewhat more painful than it has been. 3-4/10 in severity.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-03
- 2021-03-10
- 2021-04-28
-
2021-07-28
Survey response — 6 months, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: GoodFree text: Intermittent recurrence of left axillary lymphadenopathy. Lymph nodes are tender. Lasts 3-5 days and resolves spontaneously. I had this for the first time after completing vaccine series. Has recurred twice since then.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-22
Dose 3 — Pfizer-BioNTech
-
2021-10-24
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessFree text: Left axillary lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2021-10-25
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Left axillary lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2021-10-26
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Left axillary lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2021-10-27
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Left axillary lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2021-10-28
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Left axillary lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2021-10-29
Survey response — day 7, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Left axillary lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
- 2021-11-05
- 2021-11-14
- 2021-11-19
- 2021-11-26
- 2021-12-05
- 2022-01-21
- 2022-04-24
- 2022-10-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Moderna | |
| 2 | 2021-01-27 | Moderna | |
| 3 | 2021-10-22 | Pfizer-BioNTech | No |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Axillary lymphadenopathy on same side as injection
Release 1 — day 14, dose 1
Symptoms: Developed 2X4cm erythematous patch on shoulder, just below injection site. Mildly pruritic. Noticed it evening of Day 7, resolved by day 9. No systemic symptoms. Allergist thought it an inflammatory reaction (messaged photo to her)
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Lymphadenopathy on same side as injection
Systemic reaction (other): Lymphadenopathy
Systemic reaction (other): Lymphadenopathy
Systemic reaction (other): Lymphadenopathy, resolving
Release 4 — day 28, dose 2
Symptoms: Ipsilateteral lymphadenopathy somewhat more painful than it has been. 3-4/10 in severity.
Release 9 — 6 months, dose 2
Symptoms: Intermittent recurrence of left axillary lymphadenopathy. Lymph nodes are tender. Lasts 3-5 days and resolves spontaneously. I had this for the first time after completing vaccine series. Has recurred twice since then.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Left axillary lymphadenopathy
Systemic reaction (other): Left axillary lymphadenopathy
Systemic reaction (other): Left axillary lymphadenopathy
Systemic reaction (other): Left axillary lymphadenopathy
Systemic reaction (other): Left axillary lymphadenopathy
Release 10 — day 7, dose 3
Systemic reaction (other): Left axillary lymphadenopathy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Lymph node pain | ✓ | · | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Rash erythematous | ✓ | ✓ | ✓ |
| SD | Rash pruritic | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release